Compare APOG & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | APOG | PACB |
|---|---|---|
| Founded | 1949 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 820.9M | 715.5M |
| IPO Year | N/A | 2010 |
| Metric | APOG | PACB |
|---|---|---|
| Price | $38.79 | $1.84 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 6 |
| Target Price | ★ $47.00 | $2.08 |
| AVG Volume (30 Days) | 156.6K | ★ 8.7M |
| Earning Date | 01-07-2026 | 11-05-2025 |
| Dividend Yield | ★ 2.58% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.05 | N/A |
| Revenue | ★ $1,391,854,000.00 | $154,584,000.00 |
| Revenue This Year | $5.66 | $4.41 |
| Revenue Next Year | $0.83 | $11.76 |
| P/E Ratio | $19.60 | ★ N/A |
| Revenue Growth | ★ 1.19 | N/A |
| 52 Week Low | $32.77 | $0.85 |
| 52 Week High | $76.72 | $2.73 |
| Indicator | APOG | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 54.96 | 40.41 |
| Support Level | $39.78 | $2.30 |
| Resistance Level | $41.00 | $2.47 |
| Average True Range (ATR) | 1.02 | 0.17 |
| MACD | 0.21 | -0.08 |
| Stochastic Oscillator | 50.47 | 1.97 |
Apogee Enterprises Inc is a provider of architectural products and services for enclosing buildings, and high-performance glass and acrylic products used in applications for preservation, protection, and enhanced viewing. The company's operating segment consists of the Architectural Metals Segment, Architectural Services Segment, Architectural Glass Segment, and Performance Surfaces Segment. The company generates the majority of its revenue from the Architectural Metals Segment, which designs, engineers, fabricates, and finishes aluminum window, curtainwall, storefront, and entrance systems used principally in non-residential construction. The company generates revenue geographically from the United States, Canada, and Brazil, with the majority coming from the United States.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.